Whyte J, Earnshaw W C, Champoux J J, Parker L H, Stewart L, Hall N D, McHugh N J
Bath Institute for Rheumatic Diseases, School of Postgraduate Medicine, University of Bath, UK.
Clin Exp Immunol. 1995 May;100(2):214-8. doi: 10.1111/j.1365-2249.1995.tb03655.x.
Topoisomerase I (topo I) is a major systemic sclerosis (SSc)-associated autoantigen. A cDNA construct encoding full length human topo I in a recombinant baculovirus transfer vector was used to infect insect cells in culture from which recombinant protein was purified. An ELISA using recombinant protein was evaluated in 340 sera including sera from 134 patients with SSc, of whom 33 had anti-topo I antibodies detected by immunodiffusion. A high yield of pure topo I of expected molecular mass and catalytic activity was obtained. The recombinant topo I ELISA was 92% sensitive and 98% specific in detecting anti-topo I antibodies which were present almost exclusively in patients with SSc. Therefore, the potential advantages of expressing human autoantigens in eukaryotic systems for diagnostic purposes were confirmed.
拓扑异构酶I(topo I)是系统性硬化症(SSc)相关的主要自身抗原。使用重组杆状病毒转移载体中编码全长人topo I的cDNA构建体感染培养中的昆虫细胞,从中纯化重组蛋白。在340份血清中评估了使用重组蛋白的ELISA,其中包括134例SSc患者的血清,其中33例通过免疫扩散检测到抗topo I抗体。获得了预期分子量和催化活性的高产率纯topo I。重组topo I ELISA检测抗topo I抗体的敏感性为92%,特异性为98%,抗topo I抗体几乎仅存在于SSc患者中。因此,证实了在真核系统中表达人类自身抗原用于诊断目的的潜在优势。